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Introduction {#sec1}
============

After viral infection, naive antigen-specific CD8^+^ T cells clonally expand and differentiate. Massive proliferation and differentiation to effector T cells is coupled to changes in homing, function, and gene expression, leading to CD8^+^ T cell memory. Defining mechanisms that drive effective CD8^+^ T cell memory pools is critical for the design of vaccines.

Broadly, two subsets of memory CD8^+^ T cells are described: central memory CD8^+^ T cells (T~CM~) and the effector memory CD8^+^ T cells (T~EM~) ([@bib24]). "Central" memory pools are typically contracted memory populations that express lymph-node-homing markers (CD62L and CCR7). "Effector memory" subsets lack these and are found distributed in tissues, e.g., lung and liver. These pools are linked to infection with persistent viruses, the best examples being human and murine cytomegaloviruses (HCMV and MCMV).

A characteristic of the CMV immunobiology is the induction of an expanded, sustained effector-memory T cell response to specific epitopes, a phenomenon termed CD8^+^ T cell "memory inflation" ([@bib14]). In parallel, classic "non-inflating," central memory responses develop against many epitopes. Molecular profiling of CMV-specific CD8^+^ T cells in humans revealed that the development of CMV-specific CD8^+^ T cells is a dynamic process, with key features of the HCMV-specific CD8^+^ T cell phenotype installed early after infection ([@bib10]).

CD8^+^ T cell memory induced by vaccines could provide protection against complex pathogens. Whereas CMV-based vectors show promise in studies of SIV infection ([@bib9]), such viruses are complex. One technology that has shown potency in generation of antiviral T cell pools in clinical studies is based on replication-deficient adenoviral vectors. Several trials have indicated such vectors are safe and can induce substantial immune responses against pathogens such as HCV ([@bib2], [@bib7]).

Studies of vaccine-induced T cell responses in a murine model using a recombinant replication-deficient HuAd5 vector expressing lacZ (Ad-lacZ) ([@bib6]) revealed two distinct pathways for memory---an inflationary response to one epitope and a typical contracting response to a second epitope. The sustained response showed phenotypic features typical of effector memory and was enriched in tissues, whereas the reverse was true for the contracting response. Because these peptide epitopes are both derived from the same expressed transgene, this model provides a controlled system for analysis of two divergent vaccine-induced memory pools.

Here, we define the transcriptional changes in MCMV infection and Ad-LacZ vaccination and addressed to what extent parallel changes can be observed in human memory pools induced by CMV and adenoviral vectors. Our data clearly show that a subset of stable memory CD8^+^ T cell responses, whether induced by vaccine vectors or natural virus, in mouse and man, display a common molecular profile divergent from that of acute effector, central memory, and exhausted CD8^+^ T cells.

Results {#sec2}
=======

Two Functional and Transcriptionally Distinct Memory Patterns of MCMV-Specific CD8^+^ T Cells {#sec2.1}
---------------------------------------------------------------------------------------------

To establish a data set for gene expression in CD8^+^ T cell memory pools in the setting of a persistent infection, we analyzed the well-characterized model of MCMV infection. This has the advantage of a parallel human data set for comparison ([@bib10]). Infection of C57BL/6 mice with MCMV resulted in two distinct CD8^+^ T cell responses, the conventional (non-inflationary) and the expanded (inflationary) CD8^+^ T cell response in blood, spleen, and organs (liver or lung; [Figures 1](#fig1){ref-type="fig"}A, 1B; [Figure S1](#mmc1){ref-type="supplementary-material"}A). An analogous profile was observed when M45- and M38-specific CD8^+^ T cells were analyzed for IFNγ and TNFα production ([Figures 1](#fig1){ref-type="fig"}C and 1D). Furthermore, the expression of chemokines XCL1, CCL3, CCL4, CCL5, and CCL9 ([Figure 1](#fig1){ref-type="fig"}G) and LAMP1 followed the same pattern. These results confirm previous data that, after MCMV infection, two distinct types of CD8^+^ T cell responses are induced and demonstrate that both types of CD8^+^ T cells retained polyfunctionality over time ([@bib17], [@bib25]).

To generate gene-expression profiles of MCMV-specific memory and effector CD8^+^ T cells, M38- and M45-specific CD8^+^ T cells from days 7 and 50 postinfection were tetramer sorted. As naive controls, sorted CD62L^hi^ CD44^lo^ CD8^+^ T cells from naive C57BL/6 mice were used ([Figure S1](#mmc1){ref-type="supplementary-material"}B). We compared gene expression in M38- and M45-specific CD8^+^ T cells from day 7 and day 50 to naive CD8^+^ T cells. Considering genes which were \>2-fold differentially expressed over naive CD8^+^ T cells (adjusted p \< 0.01) revealed a total of 627 upregulated and 246 downregulated genes for the M45-specific population on day 7 postinfection and 400 up- and 168 downregulated genes on day 50 postinfection. For the early M38-specific population, a total of 964 genes were upregulated and 667 genes downregulated, rising to 1,088 up- and 553 downregulated genes for the late, inflating M38-specific CD8^+^ T cells ([Figure 1](#fig1){ref-type="fig"}E; GEO: [GSE73314](ncbi-geo:GSE73314){#intref0010}).

Comparison showed that the expression profiles of the four populations differed markedly ([Figure 1](#fig1){ref-type="fig"}F). M45-specific CD8^+^ T cells downregulated a large number of genes from the acute phase as they entered the central memory phase and most closely resembled naive CD8^+^ T cells. In contrast, M38-specific CD8^+^ T cells maintained expression of many of their acute phase genes (1,324 shared genes), also acquiring inflation-specific genes, totaling overall the highest number of differentially expressed genes ([Figure 1](#fig1){ref-type="fig"}F). These data confirm that MCMV, on the transcriptional level, clearly induced two distinct CD8^+^ T cell memory responses maintained in parallel.

Inflationary CD8^+^ T Cell Memory Induced by a Non-replicating Adenovirus Vector {#sec2.2}
--------------------------------------------------------------------------------

We next addressed the qualities of the vaccine-induced responses following administration of a replication-deficient βgal-recombinant adenovirus vector (Ad-LacZ) ([@bib6]). Intravenous (i.v.) immunization of C57BL/6 mice with Ad-LacZ induced two types of CD8^+^ T cell responses to βgal. βgal~96~- and βgal~497~-specific CD8^+^ T cells displayed similar expansion on day 21 postimmunization, but at day 50, βgal~96~-specific CD8^+^ T cells had further increased to 13% of total CD8^+^ T cells, whereas βgal~497~-specific CD8^+^ T cells contracted ([Figures 2](#fig2){ref-type="fig"}A and 2B). Consistent with previous studies ([@bib6]), these responses maintained functionality and were enriched in tissues such as lung and liver (data not shown).

To examine further the function and stability of vaccine-induced responses, we used an adoptive transfer approach. Cells from CD45.1^+^ mice were transferred at different time points after vaccination to CD45.2^+^-vaccinated or naive mice and tracked using tetramers. The extended CD8^+^ T cell responses were sustained over 8 weeks in the recipients, even in the absence of antigen, maintaining their phenotype (CD44^hi^, CD62L^lo^, CD27^lo^, and CD127^lo^) and distributing to tissues such as liver and lung (data not shown). Overall, these features are consistent with those of a stable memory T cell pool.

To assess the T cell transcriptome of βgal-specific CD8^+^ T cells after Ad-LacZ immunization, a gene expression array analysis of tetramer-sorted βgal-specific CD8^+^ T cells from day 21 and day 100 and of naive CD8^+^ T cells (CD62L^hi^ and CD44^lo^) was performed. By only considering genes that were at least 2-fold differentially expressed (adjusted p \< 0.01) compared to naive CD8^+^ T cells, we found a total of 937 up- and 403 downregulated genes for βgal~96~-specific (expanded) CD8^+^ T cells ([Figure 2](#fig2){ref-type="fig"}C). By directly comparing the βgal~96~-specific CD8^+^ T cell population with the βgal~497~-specific memory population, it is evident that memory βgal~96~-specific CD8^+^ T cells showed a distinct expression profile---neither identical to effector CD8^+^ T cells nor memory βgal~497~-specific CD8^+^ T cells ([Figure 2](#fig2){ref-type="fig"}C). These data confirm previous analyses indicating that two distinct memory pools are induced in parallel following Ad-lacZ immunization ([@bib6]; GEO: [GSE73314](ncbi-geo:GSE73314){#intref0015}).

Combined Analysis Reveals a Conserved Expression Profile and Phenotype {#sec2.3}
----------------------------------------------------------------------

Gene set enrichment analysis (GSEA) confirmed enrichment of the significantly up- and downregulated genes of the inflating βgal~96~- and M38-specific CD8^+^ T cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Overall, these comparisons revealed that M38- and βgal~96~-specific inflating CD8^+^ T cells shared 663 upregulated and 290 downregulated genes (compared to naive CD8^+^ T cells; [Figure S2](#mmc1){ref-type="supplementary-material"}B). We analyzed the transcriptional changes in the MCMV-induced and vaccine-induced memory pools, focusing on the cell cycle, apoptosis, TFs, and receptors for cytokines and chemokines, similar to an analysis of human CMV infection ([@bib10]).

For cell-cycle-related genes, the highly upregulated genes in the expanded populations in both models included MKI67 (Ki-6*7*), a marker of proliferation. Its expression was confirmed by FACS, and both models showed a similar profile. By day 100, the levels of proliferation in the expanded population had dropped to a similar level to those in the contracted memory ([Figures 3](#fig3){ref-type="fig"}A and 3B).

For cell survival, whereas expanded T cells maintained expression of genes seen in acute infection, contracted memory exhibited a similar expression profile to that of naive CD8^+^ T cells ([Figure 3](#fig3){ref-type="fig"}C). For example, FACS analysis of the anti-apoptotic protein Bcl-2 demonstrated downregulation in the acute phase in all responses but recovered at later time points only in the classical memory pools ([Figure 3](#fig3){ref-type="fig"}D).

"Tuning" of function through inhibitory and activation receptors occurs on T cells. We analyzed CD27 and CD357 ([@bib31]) and confirmed reduced expression of these stimulatory receptors on expanded CD8^+^ T cells (data not shown). Similarly, for both models, we extended previous data ([@bib6], [@bib27]) and showed overexpression of *Klrc1* (NKG2A), *Klrg1* (KLRG1), *Klre1*, *Klra1* (Ly-49c), and *Klrk1* (Nkg2d) in the expanded responses and unique expression of *Ly49C* mRNA, confirmed by flow cytometry analysis or qPCR (data not shown). Further analysis of inhibitory molecules associated with exhaustion ([@bib4], [@bib32]) revealed that the genes for PD-1, TIM3, CD160, LAG3, and BTLA were expressed after infection and immunization (data not shown). However, FACS analysis of PD1, TIM3, and BTLA showed high expression of these markers on days 7/21 followed by a gradual decrease in the memory phase to levels similar to naive CD8^+^ T cells ([Figure 3](#fig3){ref-type="fig"}E). Consistent with retained functionality, the expression of granzymes, such as *Gzma*, *Gzmb*, *Gzmm*, and *Gzmk* were upregulated in both models, compared to naive CD8^+^ T cells (data not shown).

Long-term maintenance of cell function is linked to cytokine signaling ("signal 3"). IL-7Rα (CD127) and IL-15Rβ (CD122) have been shown to be downregulated on inflationary CD8^+^ T cells ([@bib6], [@bib27]). We confirmed downregulation of IL-7Rα as well as downregulation of IL-6Rα ([Figure 4](#fig4){ref-type="fig"}A). These data were confirmed by FACS ([Figure 4](#fig4){ref-type="fig"}B). Inflationary CD8^+^ T cells also showed marked alterations in chemokine receptors ([Figure 4](#fig4){ref-type="fig"}A). We confirmed upregulation of CX3CR1 and relative downregulation of CXCR3 on tetramer^+^ CD8^+^ T cells by FACS ([Figure 4](#fig4){ref-type="fig"}B).

Next, we further focused on the differential expression of mRNAs of TFs ([Figure 4](#fig4){ref-type="fig"}C). T-bet and Eomes, critical for T cell memory formation, were upregulated on both specificities of CD8^+^ T cells in the acute phase: on M38- and βgal~96~-specific CD8^+^ T cells, Eomes then decreased to levels similar to that of naive CD8^+^ T cells ([Figure 4](#fig4){ref-type="fig"}D). T-bet expression, however, showed divergence in the memory phase, being low on contracting CD8^+^ T cells and remaining high on expanded CD8^+^ T cells; after adenovector vaccination, Tbet remained high on 60% of the expanded cell population at day 200 versus \<10% on contracted memory at that time point ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Relative expression of other TFs such as *Rog* (repressor of GATA), Blimp-1 (*Prdm1*), Bcl-6, *Id2*, and *Id3* were also consistent with this ([Figure S3](#mmc1){ref-type="supplementary-material"}B; data not shown).

To define distinctions between memory populations further---and the role of TFs in driving these---we used principal-component analysis (PCA) ([Figure S4](#mmc1){ref-type="supplementary-material"}). These data demonstrated that all antigen-experienced cell types cluster separately from naive cells and, compared to the "acute" sample, the classic memory pools (M45/βgal~497~) regress toward the naive cell position whereas the expanded (M38/βgal~96~) populations further extended the distance. The PCA analysis was confirmed when only using significantly modulated TFs (post-ANOVA test; [Figure S4](#mmc1){ref-type="supplementary-material"}), indicating that the principal components separating these memory populations derived from changes in a limited number of TFs.

Finally, many of these features of MCMV-induced and adenovector-induced memory cells closely resembled data from a study of HCMV infection ([@bib10]). Similar GSEA profiles were seen using expression sets based on MCMV infection (confirming a recent analysis; [@bib23]) and, strikingly, adenovirus vaccination ([Figure S4](#mmc1){ref-type="supplementary-material"}). Additionally, from GSEA analyses on the TF subset, we confirmed that TFs upregulated in HCMV ([@bib10]) are enriched in upregulated TFs post-MCMV or -adenovector, notably Tbet (ranked 1; [Figure S4](#mmc1){ref-type="supplementary-material"}).

Preserved Phenotype, Function, and TF Expression in Human-Adenoviral-Vaccine-Induced Responses {#sec2.4}
----------------------------------------------------------------------------------------------

To assess in depth whether such changes in T cell phenotype and in TF expression could be observed in human-adenovector-vaccine-induced responses, we analyzed further CD8^+^ T cells primed using a chimpanzee adenovirus strategy (ChAd3), specific for dominant HCV epitopes from NS3 (NS3~95~, HLA-A2 restricted and NS3~103~ HLA-A1 restricted). We compared them to CMV-specific responses from the same individuals. We addressed (1) whether a CMV-like effector memory phenotype could be observed and (2) whether this was associated with a Tbet-high sustained memory subset.

First, using a CYToF data set ([@bib29]), we analyzed the distribution of effector-memory-associated phenotypic markers on CMV- and HCV-specific (i.e. vaccine-induced) cells in parallel. This demonstrated a shared phenotype and one distinct from T cell responses to the non-persistent pathogen influenza ([Figure 5](#fig5){ref-type="fig"}A), most clearly seen in analysis of CD57. Overlapping populations of CD57^+^ CD127^low^ CD8^+^ T cell pools can be seen in both CMV-specific and adenovirus-induced responses. PCA revealed overlapping distribution of CMV-specific and vaccine-induced CD8^+^ T cell responses and distinct from those induced by influenza infection ([Figure 5](#fig5){ref-type="fig"}B).

Next, we analyzed the expression of two TFs---Tbet and Eomes. In bulk CD8^+^ T cell populations, these showed associations with distinct memory pools, with highest Tbet levels in Tem and Temra pools ([Figure 5](#fig5){ref-type="fig"}C). In antigen-specific cells, we identified similar patterns of Tbet and Eomes regulation in CMV- and vaccine-induced cells, with enrichment for Tbet^+^ Eomes^−^ cells in the HCV-specific vaccine populations ([Figure 5](#fig5){ref-type="fig"}D). This distribution was maintained when the virus-specific cells were analyzed following subdivision using CCR7/CD45RA expression ([Figure S5](#mmc1){ref-type="supplementary-material"}A) or within a single individual ([Figure S5](#mmc1){ref-type="supplementary-material"}B) or comparing populations that had received only adenoviral vaccination and those where there had been boosting using an MVA construct ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

The data confirmed that the adenovirus-vaccine-induced responses in humans are dominated by effector memory populations. These are high in Tbet and relatively low in Eomes, similar to CMV-specific responses from the same individuals.

Discussion {#sec3}
==========

Memory T cells are considered long-lived cells that require little if any antigen re-encounter for survival. However, continued low-level stimulation through persistence of antigen is common in vivo. We hypothesized the latter could underlie the ability of adenoviral vectors to promote T cell responses in humans. Here, by profiling CMV-specific and adenovirus-vaccine-specific memory CD8^+^ T cells, we identified patterns of CD8^+^ T cell evolution that are (1) conserved between infection and vaccination and (2) consistent between mouse and man.

Memory inflation has been shown to be independent of initial immunodominance in MCMV ([@bib15]), and inflationary epitopes are immunoproteasome independent---suggesting they are not presented on DCs ([@bib12]). The current model is that repetitive antigen presentation occurs on a non-classical antigen-presenting cell (APC), potentially in the vascular endothelium or a non-hematopoietic (nh) lymph node cell ([@bib26], [@bib30]). A separate study with a recombinant adenovirus vector concluded that nhAPC might play a role in memory ([@bib3]).

The expanded CD8^+^ T cell pools downregulated the anti-apoptotic marker Bcl-2 compared to conventional memory CD8^+^ T cells. However, the anti-apoptotic Bcl-X~L~ was uniquely upregulated. Bag3, another anti-apoptotic molecule, was highly expressed, and Bim, a pro-apoptotic marker, was downregulated ([Figure 3](#fig3){ref-type="fig"}C). Bcl-X~L~ expression can be induced by CX3CR1 ([@bib5]), which was highly upregulated in inflation ([Figure 4](#fig4){ref-type="fig"}B). Co-stimulation via 4-1BB has been shown to be critical for memory inflation ([@bib11]); because 4-1BB also induces Bcl-X~L~ ([@bib28]), we hypothesize that both CX3CR1 and 4-1BB contribute to survival of CD8^+^ T cells.

CD8^+^ effector memory pools express high levels of T-bet and to a lower extent Eomes. T-bet expression is induced by TCR signaling and amplified by IL-12- and mTOR-mediated signals ([@bib13]). This program seems to be present in HCV-specific CD8^+^ T cells induced using ChAd3 in volunteers. Such pools show sustained effector-memory phenotype, analogous to hCMV-specific responses, and a T-bet^hi^/Eomes^lo^ status, consistent with the mouse data. This is particularly resonant for HCV-specific responses, because this is the transcriptional pattern linked with clearance of virus ([@bib22]). The frequencies of responses induced by vaccination in humans do not reach those seen in "inflationary" models; however, they do reflect frequencies seen with intramuscular as opposed to (optimized) i.v. inoculation, with the same phenotypic/transcriptional changes noted ([@bib6]).

Overall, we have identified gene sets modulated in CD8^+^ T cells post-adenoviral vaccine compared to acute effector CD8^+^ T cells and to conventional memory CD8^+^ T cells. By comparing these to the "inflating" CD8^+^ T cells from MCMV-infected animals, we show the CD8^+^ T cell gene profile is distinct from that seen in exhaustion and conventional memory and sustains a memory development program likely linked with low-level antigen persistence. Such CD8^+^ T cells possess a conserved phenotypic and functional pattern, underpinned by a core set of TFs. We show that this program of memory induction is reproduced in chimpanzee-adenovirus clinical vaccine trials, with implications for immunity induced by such regimens in humans.

Experimental Procedures {#sec4}
=======================

Ethics Statement {#sec4.1}
----------------

Mouse experiments were performed according to UK Home Office regulations (project license number PPL 30/2235 and 30/2744) and after review and approval by the local ethical review board at the University of Oxford.

Viruses {#sec4.2}
-------

MCMV strain (Strain Smith; ATCC: VR194) was used and kindly provided by Professor U.H. Koszinoswki, Department of Virology, Max von Pettenkofer Institute. MCMV was propagated and titrated on NIH 3T3 cells (ECACC), stored at −80°C, and injected i.v. at a dose of 2 × 10^6^ pfus.

Adenoviral Vector {#sec4.3}
-----------------

Recombinant adenovirus expressed the βgal protein under the control of the human CMV promoter (Ad-LacZ; [@bib16]). Ad-LacZ was propagated on HER-911 cells and purified with the Vivapure AdenoPack 20 (Sartorius; Stedim Biotech). Virus titer was determined in a cytopathic effect assay ([@bib16]). Ad-LacZ was stored at −80°C in PBS and injected i.v. at a dose of 2 × 10^9^ pfus.

Mice {#sec4.4}
----

C57BL/6 mice were obtained from Harlan, kept under conventional conditions in individually ventilated cages, and fed with normal chow diet.

Peptides {#sec4.5}
--------

Peptides were MCMV, M38~316--323~ (SSPPMFRV; [@bib17]), and M45~985--993~ (HGIRNASFI; [@bib8]; Proimmune) and βgal~96--103~ (DAPIYTNV; [@bib21]) and βgal~497--504~ (ICPMYARV; [@bib20]; Mimotopes).

Antibodies {#sec4.6}
----------

Antibodies were obtained from eBioscience, BD Bioscience, BioLegend, Abcam, R&D Systems, and Jackson ImmunoResearch Laboratories.

Flow Cytometry {#sec4.7}
--------------

Single-cell suspensions were generated from the indicated organs, and 1 × 10^6^ cells were incubated with the indicated mAb at 4°C for 20 min. For PBL samples, erythrocytes were lysed with FACS Lysing Solution (BD PharMingen). Cells were analyzed by flow cytometry using a BD LSR II flow cytometer and FlowJo (Treestar), gated on viable leukocytes using the live/dead fixable near-IR dead cell stain kit from Invitrogen.

Intracellular Staining and Peptide Stimulation {#sec4.8}
----------------------------------------------

Following surface staining, cells were fixed and permeabilized using the FOXP3 Fixation/Permeabilisation Kit from eBioscience. Cells were resuspended in permeabilization buffer containing the appropriate amount of antibody and incubated for 30 min at 4°C. For peptide stimulation, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Construction of Tetrameric MHC Class I Peptide Complexes {#sec4.9}
--------------------------------------------------------

MHC class I monomers complexed with M38 (H-2Kb), M45 (H-2Db), and βgal (H-2Kb) were produced as previously ([@bib1]) and tetramerized by addition of streptavidin-PE (BD Bioscience) or streptavidin-APC (Invitrogen). Aliquots of 1 × 10^6^ cells or 100 μl of whole blood were stained using 50 μl of a solution containing tetrameric class I peptide complexes at 37°C for 20 min followed by staining with mAbs.

Sorting Cells by MACS {#sec4.10}
---------------------

CD8^+^ T cells were isolated from spleens and single-cell suspensions prepared, resuspended in MACS buffer at a concentration of 10^7^ cells/90 μl, and purified by negative selection using the CD8^+^ T cell selection kit/AutoMACS (Miltenyi Biotec).

Cell Sorting by MoFLO {#sec4.11}
---------------------

For cell sorting, at least four spleens were pooled per sort using MoFlo (Beckman Coulter Genomics). Splenocyte samples depleted of erythrocytes and enriched for CD8^+^ T cells using MACS beads were stained with saturating concentrations of antibody and tetramer, incubated for 1 hr on a rolling platform at 4°C, washed, filtered, and resuspended. Sorted cells were pelleted at 9,000 rpm for 10 min and snap frozen using methanol and dry ice. Reanalysis of sorted cells indicated a purity of over 95%.

RNA Extraction and Microarray Analyses {#sec4.12}
--------------------------------------

Total RNA was isolated from sorted cells using the mirVana Kit (Ambion). RNA integrity was checked using Agilent 2100 Bioanalyzer, and samples with a RIN value of 8 or more were used for amplification. cDNA was synthesized and cRNA made using Illumina Total Prep RNA amplification Kit (Ambion). Samples were hybridized to Illumina MouseWG-6 v2.0. For microarray data analysis, see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis of Real-Time and Flow Cytometry Data {#sec4.13}
---------------------------------------------------------

Unpaired two-tailed Student's test was used. Statistical data analysis was performed using Graph-Pad Prism version 5.0a for MACs (GraphPad Software).

Human Vaccination Protocols {#sec4.14}
---------------------------

The Ad6, ChAd3, and MVA vectors encoding the NS3-5B region of genotype 1B (Ad6-NSmut, based on sequence accession number [M58335](ncbi-n:M58335){#intref0020}) and vaccination schedules have been described previously ([@bib2], [@bib29]; [ClinicalTrial.gov](http://ClinicalTrial.gov){#intref0025} database ID: [NCT01070407](ctgov:NCT01070407){#intref0030} and [NCT01296451](ctgov:NCT01296451){#intref0035}).

Human Pentamer Staining and Flow Cytometry {#sec4.15}
------------------------------------------

Pentamer staining was as previously ([@bib29]). For staining details, see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Mass Cytometry Using CyTOF {#sec4.16}
--------------------------

Detailed methodology and validation of the mass cytometry used here are described elsewhere ([@bib18]). T cell phenotype and function were determined by mass cytometry analysis on frozen PBMCs from two volunteers receiving ChAd3-NSmut and MVA-NSmut. Samples were taken 14 weeks after MVA-NSmut boost vaccination. Two healthy controls each for CMV and FLU, previously shown to have a detectable T cell response by pentamer FACS staining, were also included. For PCA details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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====================
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![Frequency, Function, and Gene Expression Signature of MCMV-Specific CD8^+^ T Cells\
C57BL/6 mice were infected intravenously (i.v.) with 1 × 10^6^ pfus MCMV.\
(A) Tetramer staining for M38- and M45-specific CD8^**+**^ T cells on 7 and 50 days postinfection in spleen. Mean percentages of live tetramer^**+**^ CD8^**+**^ T cells are indicated (n = 8; mean ± SEM).\
(B) Time course for M38- (red) and M45- (blue) specific CD8^**+**^ T cells. Splenocytes from 0, 7, 21, 50, and 100 days postinfection mice were stained with tetramers and analyzed by flow cytometry. Mean percentages of live tetramer^**+**^ CD8^**+**^ lymphocytes are indicated (n = 8; mean ± SEM).\
(C) Representative flow cytometry plots of splenocytes producing IFNγ or TNFα stimulated with either M38 or M45 peptide in mice 7 and 50 days postinfection, gated on live lymphocytes. Numbers indicate the percentage of IFNγ- and TNFα-positive CD8^**+**^ T cells (n = 8; mean ± SEM).\
(D) Time course plotting the percentage of M38- (red) or M45- (blue) specific CD8^**+**^ T cells from the spleen producing IFNγ and TNFα after stimulation with either the M38 or M45 peptide. Mean percentage of IFNγ and TNFα producing cells within the CD8^**+**^ T cell compartment is indicated (n = 8; mean ± SEM).\
(E) Number of genes upregulated (red) and downregulated (blue) in M38- and M45-specific CD8^+^ T cells 7 and 50 days postinfection, compared to naive CD8^+^ T cells. Filter criteria of at least 2-fold change with p ≤ 0.05 compared to naive CD8^+^ T cells are shown.\
(F) Venn diagram showing the number of differentially expressed genes between M38-specific CD8^+^ T cells 7 (yellow) and 50 (red) days postinfection and M45-specific CD8^+^ T cells 7 (orange) and 50 (blue) days postinfection. Filter criteria of at least 2-fold change with p ≤ 0.05 compared to naive CD8^+^ T cells are shown. Upregulated genes are indicated in red and downregulated genes in blue.\
(G) Representative flow cytometry plots of splenocytes expressing LAMP1 or producing effector molecules stimulated with either M38 or M45 peptide in mice days 7 and 50 postinfection, gated on live lymphocytes (n = 8; ±SEM). Longitudinal flow cytometry analysis shows the percentage of M38- (red) or M45- (blue) specific CD8^+^ T cells from the spleen producing effector molecules after stimulation with either the M38 or M45 peptide. Mean percentages of LAMP1-, XCL1-, CCL3-, CCL4-, CCL5-, and CCL9-positive cells within the CD8^+^ T cell compartment are indicated (n = 8; ±SEM).\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Frequency and Gene Expression Signature of Vaccine-Induced βgal-Specific CD8^+^ T Cells\
C57BL/6 mice were immunized i.v. with 1 × 10^9^ pfus Ad-LacZ.\
(A) Representative flow cytometry plots of tetramer staining for βgal~96~- and βgal~497~-specific CD8^+^ T cells on 21 and 100 days postimmunization in the spleen. Mean percentage of live tetramer-positive CD8^+^ T cells is indicated (n = 10; mean ± SEM).\
(B) Time course for βgal~96~- (red) and βgal~497~- (blue) specific CD8^+^ T cells. Splenocytes from 0, 21, 50, and 100 days postimmunization were stained with tetramers and analyzed by flow cytometry. Mean percentages of live tetramer-positive CD8^+^ T cells are indicated (n = 5; mean ± SEM).\
(C) Venn diagram showing the number of differentially expressed genes between βgal~96~-specific CD8^+^ T cells 21 (yellow) and 100 (red) days postimmunization and βgal~497~-specific CD8^+^ T cells 21 (orange) and 100 (blue) days postimmunization. Filter criteria of at least 2-fold change with p ≤ 0.05 compared to naive CD8^+^ T cells are shown. Upregulated genes are indicated in red and downregulated genes in blue.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Turnover, Survival, and Expression of Inhibitory Receptors on Sustained Memory CD8^+^ T Cell Pools\
C57BL/6 mice were infected i.v. with 1 × 10^6^ pfus MCMV or immunized i.v. with 1 × 10^9^ pfus Ad-LacZ.\
(A) Longitudinal analysis of the percentage of cells expressing Ki67 on MCMV-specific (left panel) and βgal-specific CD8^**+**^ T cells (right panel) in the spleen on days 0, 7, 21, 50, and 100 postinfection or postvaccination, measured by flow cytometry (n = 6--8; ±SEM).\
(B) Representative flow cytometry plots show the expression of Ki67 in the spleen on days 7 and 50 postinfection or d21 and d100 postvaccination gated on live M38**-** or M45-specific (left panel) and βgal~96~- or βgal~497~-specific (right panel) CD8 T cells.\
(C) Heatmap showing mRNA expression levels of proteins involved in apoptosis measured by microarray analysis of naive, M38-, and M45-specific CD8^**+**^ T cells days 7 and 50 postinfection (left panel) and naive CD8^**+**^ T cells, βgal~96~-, and βgal~497~-specific CD8^**+**^ T cells days 21 and 100 postvaccination (right panel). Shades of red indicate upregulated genes, and shades of blue indicate downregulated genes. Filter criteria of at least 2-fold changes with p ≤ 0.05, compared to naive CD8^**+**^ T cells, are shown.\
(D) Longitudinal analysis of the percentage of cells expressing Bcl2 on MCMV-specific (left panel) and βgal-specific CD8^**+**^ T cells (right panel) in the spleen on days 0, 7, 21, 50, and 100 postinfection or postvaccination, measured by flow cytometry (n = 6--8; ±SEM).\
(E) Flow cytometry analysis showing the percentage or the MFI of cells expressing the inhibitory receptors PD1, TIM3, and BTLA on M38- (red) and M45-specific CD8^+^ T cells (blue; n = 6--8; ±SEM) and on βgal~96~- (red) and βgal~497~-specific (blue) CD8^+^ T cells in the spleen (n = 6--8; ±SEM). Histograms show expression of PD-1, TIM-3, and BTLA and are gated on live naive (green) M38/βgal~96~-specific (red) and M45/βgal~497~-specific CD8^+^ T cells (blue).](gr3){#fig3}

![Distinct Cytokine and Chemokine Receptor Expression and Individual Transcription Regulator Profile on Expanded CD8^+^ T Cells Compared to Conventional Memory CD8^+^ T Cells\
(A) Heatmap showing mRNA expression levels of cytokine and chemokine receptors measured by microarray analysis of naive, M38-, and M45-specific CD8^**+**^ T cells days 7 and 50 postinfection (left panel) and naive, βgal~96~-, and βgal~497~-specific CD8^**+**^ T cells days 21 and 100 postvaccination (right panel). Shades of red indicate upregulated genes, and shades of blue indicate downregulated genes. Filter criteria of at least 2-fold changes with p ≤ 0.05, compared to naive CD8^**+**^ T cells, are shown.\
(B) Longitudinal flow cytometry analysis showing the percentage of IL-6Rα (CD126), CX3CR1, and CXCR3 expression on M38/βgal~96~- (red) and M45/βgal~497~-specific CD8^**+**^ T cells (blue) in the spleen at days 0, 7, 21, 50, and 100 postinfection/immunization (n = 6--8; ±SEM). Histograms show expression of indicated markers, gated on live naive (green) M38/βgal~96~- (red) and M45/βgal~497~-specific CD8^**+**^ T cells (blue).\
(C) Heatmap showing mRNA expression levels of transcriptional regulators measured by microarray analysis of naive, M38-, and M45-specific CD8^**+**^ T cells days 7 and 50 postinfection (left panel) and naive CD8^**+**^ T cells and βgal~96~- and βgal~497~-specific CD8^**+**^ T cells days 21 and 100 postvaccination (right panel). Shades of red indicate upregulated genes, and shades of blue indicate downregulated genes. Filter criteria of at least 2-fold changes with p ≤ 0.05, compared to naive CD8^**+**^ T cells, are shown.\
(D) Flow cytometry analysis showing the MFI of cells expressing the TFs EOMES and Tbet on M38- (red) and M45-specific CD8^+^ T cells (blue; n = 6--8; ±SEM) and on βgal~96~- (red) and βgal~497~-specific (blue) CD8^+^ T cells in the spleen (n = 5--9; ±SEM). Histograms show expression of EOMES and Tbet and are gated on live naive (green), M38/βgal~96~-specific CD8^+^ T cells (red), and M45/βgal~497~-specific CD8^+^ T cells (blue).\
See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Mass Cytometry and FACS Reveal a Shared Phenotype and TF Expression of Human T Cells Induced by Virally Vectored Vaccines and CMV\
(A and B) The memory T cell response induced by heterologous prime-boost vaccination with ChAd3-NSmut and MVA-NSmut were compared with that seen after natural infection with flu and CMV by CyTOF. (A) Example plots of intracellular cytokine staining of stimulated or surface and internal markers on un-stimulated cells are shown. Bulk CD8s are shown as density plots in gray, and Ag-specific cells (n = 2) are overlaid as black (14 weeks post-MVA boost vaccination), red (flu-specific), or blue dots (CMV-specific). (B) 3D-PCA of vaccine-induced CD8^+^ T cells is shown. The first three principal components were plotted in PyMOL (PC1 axis in red, PC2 axis in green, and PC3 axis in blue). In the top figure, gray dots represent single bulk CD8 T cells. Ag-specific cells (n = 2) are overlaid as white (14 weeks post-MVA boost vaccination), red (flu-specific), or blue (CMV-specific) dots. Ag-specific cells alone are shown in the bottom left panel. In the bottom right panel, the bulk CD8^+^ T cells are shown, colored according to their relative expression of the marker CD57 in CD8^+^ T cells, from the highest expression in red to the lowest in blue.\
(C and D) Eomes and T-bet expression on bulk CD8^+^ T cells by FACS (C) and their co-expression on CD8^+^ T cell subsets (naive: CD45RA^+^CCR7^+^; Tcm: CD45RA^−^CCR7^+^; Tem: CD45RA^−^CCR7^−^; Temra: CD45RA^+^CCR7^−^; n = 22; D). Bars are at median. All comparisons of T-bet and Eomes expression between any two T cell subsets were highly significant (p \< 0.0001^∗∗∗∗^) unless stated.\
(E) HCV-specific memory CD8^+^ T cells induced by virally vectored vaccine regimes (black; 8--26 weeks post-boost vaccination) or by natural infection with CMV (gray) were identified by pentamer staining, and their expression of T-bet and Eomes was assessed (CMV n = 8; Ad/Ad vaccination n = 8; Ad/MVA n = 6). Bars are at median.\
(F) Example FACS plots showing T-bet versus Eomes co-staining and gating controls.\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}
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